Показано 0 из 0
Дата |
---|
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.68
|
1.72
|
1.71
|
1.68
|
1.71
|
1.69
|
|
|
6 791.30
|
19.00
|
1.68
|
1.72
|
1.69
|
1.68
|
1.72
|
1.71
|
|
|
3 231.40
|
14.00
|
1.68
|
1.70
|
1.68
|
1.68
|
1.71
|
1.70
|
|
|
8 414.62
|
14.00
|
1.65
|
1.69
|
1.65
|
1.65
|
1.69
|
1.69
|
|
|
6 134.00
|
11.00
|
1.62
|
1.69
|
1.65
|
1.62
|
1.66
|
1.64
|
|
|
6 770.78
|
17.00
|
1.64
|
1.70
|
1.66
|
1.64
|
1.67
|
1.65
|
|
|
5 147.94
|
19.00
|
1.65
|
1.70
|
1.71
|
1.65
|
1.71
|
1.66
|
|
|
25 457.44
|
83.00
|
1.68
|
1.73
|
1.70
|
1.67
|
1.70
|
1.69
|
|
|
7 071.60
|
25.00
|
1.65
|
1.70
|
1.68
|
1.63
|
1.71
|
1.65
|
|
|
21 948.50
|
48.00
|
1.65
|
1.75
|
1.68
|
1.60
|
1.77
|
1.70
|
|
|
57 958.00
|
164.00
|
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada.